Schonfeld Strategic Advisors LLC Insmed Inc Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Insmed Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 39,832 shares of INSM stock, worth $2.94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

39,832

Previous 77,972 48.91%

Holding current value

$2.94 Million

Previous $5.22 Million 44.35%

% of portfolio

0.02%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $2.36 Million - $3.01 Million	-38,140 Reduced 48.91%	39,832 $2.91 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $6.42 Million - $20.4 Million	-291,946 Reduced 78.92%	77,972 $5.22 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $7.47 Million - $8.7 Million	290,544 Added 366.04%	369,918 $10 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $2.9 Million - $3.94 Million	-124,026 Reduced 60.98%	79,374 $2.46 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $4.04 Million - $5.48 Million	203,400 New	203,400 $5.14 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $448,141 - $598,900	27,561 Added 272.88%	37,661 $642,000
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $220,383 - $300,463	-12,979 Reduced 56.24%	10,100 $201,000
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $879,862 - $1.19 Million	-42,139 Reduced 64.61%	23,079 $497,000
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $1.11 Million - $1.68 Million	65,218 New	65,218 $1.29 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $736,209 - $1.01 Million	-22,807 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $363,719 - $468,845	11,565 Added 102.87%	22,807 $759,000
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $292,292 - $387,849	11,242 New	11,242 $0
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $212,784 - $329,736	-13,200 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $151,802 - $252,644	-9,800 Reduced 42.61%	13,200 $233,000
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $529,000 - $740,370	23,000 New	23,000 $589,000
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $240,671 - $289,388	-9,106 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $105,720 - $284,198	9,106	9,106 $284,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Insmed Inc Transaction History